Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 ...
Google DeepMind is holding back from publishing GenAI research over competition fears
Google’s DeepMind is reportedly holding back from publishing AI research papers over fears of losing its competitive edge.
Google DeepMind CEO says his passion for chess led to his career in AI
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
DeepMind is holding back release of AI research to give Google an edge
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
How a Love of Chess Led the CEO of Google's DeepMind to a Career in AI — and a Nobel Prize
Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
DeepMind slows down research releases in battle to keep competitive edge
Google’s AI arm led by Demis Hassabis makes it harder for its researchers to publish studies in major change in approach ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
GEN - Genetic Engineering and Biotechnology News1d
DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
University of Cambridge9d
Nobel laureate and Cambridge alumnus Sir Demis Hassabis heralds a new era of 'digital speed' drug discovery
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...